QNCX - Quince Therapeutics, Inc. Stock Price, Fair Value and News
0.90USD-0.02 (-2.17%)Market Closed
Latest Insider Trading transactions for QNCX
| Datesorted ascending | Name | Buy/Sell | $ Value | # Shares | Avg. Price | Title |
|---|---|---|---|---|---|---|
| 2024-01-16 | Premium | acquired | Premium | Premium | Premium | CHIEF EXECUTIVE OFFICER |
| 2023-12-14 | Premium | bought | Premium | Premium | Premium | - |
| 2023-12-13 | Premium | bought | Premium | Premium | Premium | - |
| 2023-12-12 | Premium | bought | Premium | Premium | Premium | - |
| 2023-12-12 | Premium | bought | Premium | Premium | Premium | - |
| 2023-12-07 | Premium | bought | Premium | Premium | Premium | - |
| 2023-12-06 | Premium | bought | Premium | Premium | Premium | - |
| 2023-12-05 | Premium | bought | Premium | Premium | Premium | - |
| 2023-12-01 | Premium | bought | Premium | Premium | Premium | - |
| 2023-11-30 | Premium | bought | Premium | Premium | Premium | - |
| 2023-11-29 | Premium | bought | Premium | Premium | Premium | - |
| 2023-08-31 | Premium | bought | Premium | Premium | Premium | - |
| 2023-08-30 | Premium | bought | Premium | Premium | Premium | - |
| 2023-08-17 | Premium | bought | Premium | Premium | Premium | - |
| 2023-08-16 | Premium | bought | Premium | Premium | Premium | - |
| 2023-08-15 | Premium | bought | Premium | Premium | Premium | - |
| 2023-08-10 | Premium | bought | Premium | Premium | Premium | Chief Executive Officer |
| 2023-08-08 | Premium | bought | Premium | Premium | Premium | Chief Business Officer |
| 2023-08-08 | Premium | bought | Premium | Premium | Premium | - |
| 2023-08-08 | Premium | bought | Premium | Premium | Premium | Chief Executive Officer |
| 2023-03-06 | Premium | sold | Premium | Premium | Premium | Chief Accounting Officer & VP |
| 2022-12-05 | Premium | sold (taxes) | Premium | Premium | Premium | Chief Accounting Officer & VP |
| 2022-09-06 | Premium | sold (taxes) | Premium | Premium | Premium | Chief Accounting Officer & VP |